Johnson & Johnson (JNJ) has been ranked as the #10 broker pick among 30 stocks in the Dow Jones Industrial Average, according to a recent study by ETF Channel. In the broader S&P 500 index, JNJ holds the #120 position out of 500 stocks. The study highlights a strong showing for Johnson & Johnson in analyst recommendations.
As of midday Tuesday, JNJ’s stock is up approximately 1.4%. The company operates within the Drugs & Pharmaceuticals sector, competing with firms like Eli Lilly (LLY), which is up about 0.6%, and Novartis (NVS), trading down by 0.2%.
